Lignocaine HCL 2 percentage with Adrenaline 30 ml Injection suitable for ophthalmic use also,Lignoc
Indian Army
DODA, JAMMU & KASHMIR
Progress
Quantity
15140
Category
Adrenaline Tartrate 1 each 1000 1 ml injection
Bid Type
Two Packet Bid
Public procurement opportunity for Indian Army Paracetamol withcysteine Hcl monohydrate infusion 1000 mg per 100 ml, Paracetamol syrup 125mg per 5ml bottle of 60 ml, Adrenaline Tartrate 1 each 1000 1 ml injection, Chlorzoxazone 500mg diclofenacenac sodium 50 mg paracetamol 325 mg Tablet, Metronidazole 400 mg Tablet, Tranexamic acid 500mg per 5ml injection, Telmisartan 40mg hydrochlorothiazide 12 point 5 mg tablet, Mupirocin 2 percent ointment tube of 5 gm, Acetazolamide 250 mg Tablet, Antispasmodic tablet containing mefenamic acid 250 mg and dicyclomine hcl 10mg, Dicyclomine hcl 20 mg Injection, Loperamide 2mg tablet, Etophylline BP 84 point 7 mg and theophylline 25 point 3mg per 2ml injection, Paracetamol 150 mg per ml 2ml iv injection, Syrup paracetamol 125mg ibuprofen 200mg per 5ml bott of 60 ml, Povidone iodine oint 10 percent tube of 10 gm, Clonazepam zero point 5 mg Tablet, Hyoscine bromide injection 20mg per ml 1ml injection, Carboxy methyl cellulose 1 percent eye drop bott of 10 ml, Capsule probiotic multibacillary 4 or more organisms, Metronidazoleinjection for iv use containing 500 mg per bott of 100 ml in RI BHOI, MEGHALAYA. Quantity: 15140 issued by. Submission Deadline: 20-06-2025 20: 00: 00. View full details and respond.
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Army
DODA, JAMMU & KASHMIR
Indian Army
LEH, JAMMU & KASHMIR
Border Road Organisation
DEHRADUN, UTTARAKHAND
National Health Mission
NASHIK, MAHARASHTRA
Indian Army
KUPWARA, JAMMU & KASHMIR
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Paracetamol withcysteine Hcl monohydrate infusion 1000 mg per 100 ml | Paracetamol withcysteine Hcl monohydrate infusion 1000 mg per 100 ml | 150 | bott | farha | 21 |
| 2 | Paracetamol syrup 125mg per 5ml bottle of 60 ml | Paracetamol syrup 125mg per 5ml bottle of 60 ml | 450 | no | farha | 21 |
| 3 | Adrenaline Tartrate 1 each 1000 1 ml injection | Adrenaline Tartrate 1 each 1000 1 ml injection | 90 | amp per vial | farha | 21 |
| 4 | Chlorzoxazone 500mg diclofenacenac sodium 50 mg paracetamol 325 mg Tablet | Chlorzoxazone 500mg diclofenacenac sodium 50 mg paracetamol 325 mg Tablet | 6,000 | no | farha | 21 |
| 5 | Metronidazole 400 mg Tablet | Metronidazole 400 mg Tablet | 900 | no | farha | 21 |
| 6 | Tranexamic acid 500mg per 5ml injection | Tranexamic acid 500mg per 5ml injection | 40 | amp per vial | farha | 21 |
| 7 | Telmisartan 40mg hydrochlorothiazide 12 point 5 mg tablet | Telmisartan 40mg hydrochlorothiazide 12 point 5 mg tablet | 500 | no | farha | 21 |
| 8 | Mupirocin 2 percent ointment tube of 5 gm | Mupirocin 2 percent ointment tube of 5 gm | 300 | tube | farha | 21 |
| 9 | Acetazolamide 250 mg Tablet | Acetazolamide 250 mg Tablet | 1,800 | no | farha | 21 |
| 10 | Antispasmodic tablet containing mefenamic acid 250 mg and dicyclomine hcl 10mg | Antispasmodic tablet containing mefenamic acid 250 mg and dicyclomine hcl 10mg | 1,500 | no | farha | 21 |
| 11 | Dicyclomine hcl 20 mg Injection | Dicyclomine hcl 20 mg Injection | 300 | amp per vial | farha | 21 |
| 12 | Loperamide 2mg tablet | Loperamide 2mg tablet | 600 | no | farha | 21 |
| 13 | Etophylline BP 84 point 7 mg and theophylline 25 point 3mg per 2ml injection | Etophylline BP 84 point 7 mg and theophylline 25 point 3mg per 2ml injection | 60 | amp per vial | farha | 21 |
| 14 | Paracetamol 150 mg per ml 2ml iv injection | Paracetamol 150 mg per ml 2ml iv injection | 300 | amp per vial | farha | 21 |
| 15 | Syrup paracetamol 125mg ibuprofen 200mg per 5ml bott of 60 ml | Syrup paracetamol 125mg ibuprofen 200mg per 5ml bott of 60 ml | 150 | bott | farha | 21 |
| 16 | Povidone iodine oint 10 percent tube of 10 gm | Povidone iodine oint 10 percent tube of 10 gm | 90 | tube | farha | 21 |
| 17 | Clonazepam zero point 5 mg Tablet | Clonazepam zero point 5 mg Tablet | 300 | no | farha | 21 |
| 18 | Hyoscine bromide injection 20mg per ml 1ml injection | Hyoscine bromide injection 20mg per ml 1ml injection | 90 | amp per vial | farha | 21 |
| 19 | Carboxy methyl cellulose 1 percent eye drop bott of 10 ml | Carboxy methyl cellulose 1 percent eye drop bott of 10 ml | 200 | bott | farha | 21 |
| 20 | Capsule probiotic multibacillary 4 or more organisms | Capsule probiotic multibacillary 4 or more organisms | 1,200 | no | farha | 21 |
| 21 | Metronidazoleinjection for iv use containing 500 mg per bott of 100 ml | Metronidazoleinjection for iv use containing 500 mg per bott of 100 ml | 120 | bott | farha | 21 |
Discover companies most likely to bid on this tender
Experience Criteria
Bidder Turnover
OEM Authorization Certificate
Additional Doc 1 (Requested in ATC) *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Key insights about MEGHALAYA tender market
The eligibility requirements include being a registered entity, having valid certifications from health authorities, and demonstrating experience in supplying pharmaceutical products. Bidders must showcase their compliance with regulations governing the pharmaceutical sector and confirm their operational capabilities to fulfill contract demands effectively.
Bidders must comply with stringent technical specifications to assure product safety and efficacy. This includes adherence to quality standards mandated by the Ministry of Defence, as well as confirmation of the validity of manufacturing facilities and the provision of product-specific data sheets displaying compliance with regulatory guidelines.
The submission methods require that all documents, including technical and financial bids, be uploaded through the designated online portal. Bidders must follow specific formatting guidelines as outlined in the tender documents, ensuring that all required submissions are completed accurately by the stipulated deadline.
The financial evaluation process will take place after a successful technical evaluation. Bids will be assessed based on the pricing of the required pharmaceutical products. Factors such as previous government contracts and financial stability will be considered during this phase to ensure the most competitive offer is selected.
Although specific benefits for Micro, Small, and Medium Enterprises (MSEs) are not listed in this tender, it is advised that bidders review existing policies supporting MSE participation in government procurement. Additionally, adherence to 'Make in India' initiatives and local content requirements may enhance their competitive edge.
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS